The content on this site – including trademarks, logos, photos, descriptions and other original material – should not be reproduced without our prior written consent. “Kinled Holding” is one of our registered trademarks. Other trademarks, such as those of our portfolio companies, are owned by their respective owners.

This site may from time to time include links to other websites as a convenience. We do not make any express or implied warranties with regard to the information, material, products or services that are contained on or accessible through linked websites and have no responsibility for or liability arising out of or related to such websites or their contents.

 

This site is for general information purposes only and is subject to change without notice. Nothing on this site should be construed as an offer, invitation or general solicitation to buy or sell any investment or securities, provide investment advisory services, make personal recommendations or to engage in any other transaction, and must not be relied upon in connection with any investment decision. Information on this site is not intended to and does not constitute financial, accounting, tax, legal, investment, consulting or other professional advice or services.

​

This Kinled website is for general information purposes only and is subject to change without notice. Kinled, where “Kinled” and “Kinled Holding” shall mean Kinled Austria GmbH, a private company limited by shares registered in Vienna, and its affiliates, partners, and subsidiaries including but not limited to Kinled Investments Limited, Kinled Life Science Ventures Limited, Kinled (Vaduz) Limited, Kinled Austria GMbH, and Kinled Group Ltd, and can include any portfolio company held via participation in a Kinled Partner-Fund, defined as a regulated fund where Kinled is a Limited Partner, or Founder, such as CEBINA Bridge Capital Limited, DanubeNeuro Limited, Danube BioVentures, or Partner and/or Limited Partner, such as Concentric Team Technology I LP, D2 Fund 1 LP, Maki VC Fund III Ky, MedScience Ventures LLC, Oxford Capital Partners LLP, Pureos BioVentures LP, Speedinvest Opportunity I EuVECA GmbH & Co KG, Speedinvest III EuVECA GmbH & Co KG, Verve Ventures Capital Partner LP, & Zero One Hundred RAIF F.C.I.C. Plc., and/or a portfolio company in which a Kinled Director is also a Director of the investment vehicle or investing entity, which is unregulated, and can be reasonably deemed to exert some degree of control over the investment decisions.

Nothing contained within this update should be construed as an offer, invitation or general solicitation to buy or sell any investment or securities, provide investment advisory services, make personal recommendations or to engage in any other transaction, and must not be relied upon in connection with any investment decision. Information contained within this update is not intended and does not constitute financial, accounting, tax, legal, investment, consulting or other professional advice or services.